Waist Circumference Is the Best Index for Obesity-Related Cardiovascular Disease Risk in Individuals with Spinal Cord Injury

被引:70
作者
Ravensbergen, Henrike Joanna Cornelie [1 ,2 ]
Lear, Scott Alexander [1 ,3 ,4 ]
Claydon, Victoria Elizabeth [1 ,2 ]
机构
[1] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada
[2] Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada
[3] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada
[4] Providence Hlth Care, Div Cardiol, Vancouver, BC, Canada
关键词
BODY-MASS INDEX; VISCERAL ADIPOSE-TISSUE; CORONARY-HEART-DISEASE; TO-HIP RATIO; NECK CIRCUMFERENCE; ABDOMINAL OBESITY; ORTHOSTATIC HYPOTENSION; CARDIOMETABOLIC RISK; CLINICAL-ASSESSMENT; METABOLIC SYNDROME;
D O I
10.1089/neu.2013.3042
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Obesity is an important identifier of cardiovascular disease (CVD) risk, but is challenging to determine accurately in individuals with spinal cord injury (SCI). Body mass index (BMI) is used worldwide as a simple indicator of obesity, but is difficult to measure in individuals with SCI. Furthermore, standard BMI cutoffs underestimate obesity in this population. Therefore, we aimed to identify the best marker of obesity in individuals with SCI, considering both practicality, and ability to detect adiposity and CVD risk. Five anthropometric measures were evaluated: BMI; waist circumference (WC); waist-To-height ratio (WHtR); waist-To-hip ratio; and neck circumference. We evaluated relationships between these measures and abdominal and total body-fat percentage, seven cardiovascular metabolic risk factors (fasting insulin, glucose, glucose tolerance, triglycerides, high-density lipoprotein, low-density lipoprotein, and total cholesterol), and the Framingham risk score. BMI, WC, and WHtR were correlated with abdominal fat percentage. WC and WHtR were correlated with five metabolic risk factors as well as the Framingham risk score. WC is a more practical measure for an SCI population. The optimal cutoff for identifying adverse CVD risk in individuals with SCI was identified as WC ≥94 cm, with 100% sensitivity and 79% specificity. We propose that WC is a simple, more sensitive alternative to BMI in this population that is easy to use in multiple settings. The cutoff provides a simple tool to predict adverse CVD risk profiles that can be used to guide risk management, as well as as a practical aid for individuals with SCI to maintain a healthy body composition. © Copyright 2014, Mary Ann Liebert, Inc. 2014.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 55 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]  
[Anonymous], 2000, WHO TECHN REP SER, V894, pi
[4]   The effect of residual neurological deficit on oral glucose tolerance in persons with chronic spinal cord injury [J].
Bauman, WA ;
Adkins, RH ;
Spungen, AM ;
Waters, RL .
SPINAL CORD, 1999, 37 (11) :765-771
[5]   Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury [J].
Bauman, WA ;
Kahn, NN ;
Grimm, DR ;
Spungen, AM .
SPINAL CORD, 1999, 37 (09) :601-616
[6]   Neck circumference as a simple screening measure for identifying overweight and obese patients [J].
Ben-Noun, L ;
Sohar, E ;
Laor, A .
OBESITY RESEARCH, 2001, 9 (08) :470-477
[7]   A review of body mass index and waist circumference as markers of obesity and coronary heart disease risk in persons with chronic spinal cord injury [J].
Buchholz, AC ;
Bugaresti, JM .
SPINAL CORD, 2005, 43 (09) :513-518
[8]   Orthostatic hypotension following spinal cord injury: understanding clinical pathophysiology [J].
Claydon, V. E. ;
Steeves, J. D. ;
Krassioukov, A. .
SPINAL CORD, 2006, 44 (06) :341-351
[9]   Orthostatic hypotension and autonomic pathways after spinal cord injury [J].
Claydon, Victoria E. ;
Krassioukov, Andrei V. .
JOURNAL OF NEUROTRAUMA, 2006, 23 (12) :1713-1725
[10]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497